A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag®

医学 体外循环 红细胞压积 体表面积 凝血因子 动脉 凝血时间激活 心脏外科 外科 麻醉 心脏病学 内科学
作者
Keith A. Samolyk,Scott R. Beckmann,Randall C. Bissinger
出处
期刊:Perfusion [SAGE Publishing]
卷期号:20 (6): 343-349 被引量:28
标识
DOI:10.1191/0267659105pf831oa
摘要

Recent data independently linking allogeneic blood use to increased morbidity and mortality after cardiopulmonary bypass (CPB) warrants the study of new methods to employ unique and familiar technology to reduce allogeneic blood exposure. The Hemobag allows the open-heart team to concentrate residual CPB circuit contents and return a high volume of autologous clotting factors and blood cells to the patient. Fifty patients from all candidates were arbitrarily selected to receive the Hemobag (HB) therapy. A retrospective control group of 50 non-Hemobag (NHB) patients were matched to the HB group patient-by-patient for comparison according to surgeon, type of procedure, age, body surface area (BSA), body weight and CPB time. Many efforts to conserve blood (Cell Saver and ANH) were employed in both groups. Post-CPB cell washing of circuit contents was additionally employed in the control group. There were no significant differences between the HB and NHB groups in regard to patient morphology, pre-op cell concentrations, distribution of surgeon or procedures (41% valve, 16% valve/coronary artery bypass graft (CABG), balance CABG), pump and ischemic times and Bayes National Risk scores. The average volume returned to the patient from the HB was 817+/-198 mL (1 SD). Average processing time was 11 min. The Hemobag contained an average platelet count of 230+/-80 K/mm3, fibrinogen concentration of 413 +/- 171 mg/dl, total protein of 8.0+/-2.8 gm/dl, albumin of 4.4+/-1.2 gm/dl and hematocrit of 43+/-7%. Factor VII, IX and X levels in three HB contents averaged 259% greater than baseline. Substantial reductions were achieved in both allogeneic blood product avoidance and cost to the hospital with use of the HB. Infusion of the Hemobag concentrate appears to recover safely substantial proteins, clotting factor and cell concentration for all types of cardiac procedures, maintaining the security of a primed circuit.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Yeong完成签到,获得积分10
刚刚
WTH完成签到,获得积分10
刚刚
nanxun完成签到,获得积分10
刚刚
执着乐双完成签到,获得积分10
1秒前
泡沫完成签到,获得积分10
2秒前
外向保温杯完成签到,获得积分10
2秒前
老胡应助云瀑山采纳,获得200
3秒前
3秒前
李喜喜发布了新的文献求助10
3秒前
Z_butterfly完成签到,获得积分10
3秒前
DDangyl完成签到,获得积分10
3秒前
kyt完成签到,获得积分10
3秒前
RAE完成签到,获得积分10
4秒前
无限师完成签到,获得积分10
4秒前
bkagyin应助小涛涛采纳,获得10
5秒前
Hello应助RichieXU采纳,获得10
6秒前
6秒前
大模型应助Yuan88采纳,获得10
6秒前
葡萄葡萄萄完成签到,获得积分20
7秒前
努力努力完成签到,获得积分10
7秒前
Nefelibata完成签到,获得积分10
7秒前
11完成签到,获得积分10
8秒前
饱满跳跳糖完成签到,获得积分10
8秒前
liangliang完成签到,获得积分10
8秒前
野性的马里奥完成签到,获得积分10
9秒前
sian完成签到,获得积分10
9秒前
受伤问凝完成签到 ,获得积分10
9秒前
hbb完成签到,获得积分10
9秒前
June-ho发布了新的文献求助10
10秒前
qwp完成签到,获得积分10
10秒前
dearcih完成签到,获得积分10
10秒前
zhangxiaoqing完成签到,获得积分10
10秒前
缓慢鸽子应助李喜喜采纳,获得20
10秒前
10秒前
windli完成签到,获得积分10
11秒前
执着幻桃完成签到,获得积分10
11秒前
慕容绝义完成签到,获得积分10
11秒前
我是老大应助自由的摇伽采纳,获得10
12秒前
Eric_Zhou完成签到,获得积分10
12秒前
俏皮凝梦完成签到,获得积分10
12秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7298539
求助须知:如何正确求助?哪些是违规求助? 8916989
关于积分的说明 18880573
捐赠科研通 6963638
什么是DOI,文献DOI怎么找? 3210680
关于科研通互助平台的介绍 2380000
邀请新用户注册赠送积分活动 2187188